06 April 2023 | Thursday | News
Image Source : Public Domain
Jingsong Wang, MD, PhD, Chairman of Nona Biosciences, said, " By combining our respective expertise in antibody engineering and the disease area, we are confident that this collaboration will yield groundbreaking discoveries and bring us closer to eradicating the most challenging infectious diseases."
Dr. Torsten Mummenbrauer, CEO of ExeVir, added, " The collaboration with Nona Biosciences will be an important support in our ongoing research on bringing new infectious diseases treatments to patients and will deliver additional options to ExeVir's pipeline in infectious diseases.
Most Read
Bio Jobs
News
Editor Picks